Nel ASA: Strengthens its industry leadership as the final investment decision has been taken to industrialize the Next Generation Pressurized Alkaline platform

Nel's board has taken a final investment decision to build up to 1 GW of production capacity for its Next Generation Pressurized Alkaline electrolyser at Herøya after successful full‑scale prototype testing, with commercial launch targeted in H1 2026 and scaled deliveries in 2027. The project is supported by up to EUR 135 million from the EU Innovation Fund (covering up to 60% of relevant CAPEX/OPEX) and the initial 1 GW is estimated to require about NOK 300 million before grants, with an expected first payment in excess of EUR 10 million; the funding framework could enable up to 4 GW of annual production output. Nel says the modular, skid‑based, outdoor-capable design materially lowers system CAPEX and improves energy efficiency to reduce levelized cost of hydrogen and unlock previously marginal business cases, and the company will review the book values of two idling 500 MW atmospheric lines at Herøya following commercialization.

Analysis

Nel ASA's board has taken a final investment decision to construct up to 1 GW of Next Generation Pressurized Alkaline electrolyser capacity at the Herøya facility following seven years of development and successful full‑scale prototype testing. The company targets a commercial launch in H1 2026 and the ability to deliver at scale in 2027, establishing clear near‑term operational milestones.

The pressurized alkaline platform is described as delivering market‑leading system efficiency while materially reducing system CAPEX and improving energy efficiency to lower levelized cost of hydrogen (LCOH). A fully modular, factory‑tested skid design that operates outdoors is intended to simplify engineering, logistics and installation compared with atmospheric alkaline lines.

The project is supported by up to EUR 135 million from the EU Innovation Fund covering up to 60% of relevant CAPEX/OPEX, enabling up to 4 GW annual production output; the initial 1 GW is estimated at roughly NOK 300 million before grants and is expected to unlock a first payment in excess of EUR 10 million. CAPEX is expected to be incurred through 2026–2027 and grant payments are milestone‑based, which reduces upfront funding pressure but ties cash flows to execution.

If the technology scales as claimed it could unlock previously marginal hydrogen projects and improve Nel's competitive position, but commercialization and scaling risks remain until H1 2026 and the 2027 ramp. Investors should monitor execution on milestones and Nel's planned review of the two idling 500 MW atmospheric lines for potential impairments or redeployments that would affect asset values.

Key Decisions for Investors

• Consider a constructive overweight stance on NEL given prototype validation and substantial EU grant support, but keep position sizes modest pending commercialization evidence
• Monitor near‑term catalysts closely: first EU payment (in excess of EUR 10m), H1 2026 commercialization announcements, and CAPEX burn across 2026–2027
• Employ staging or hedging strategies until production‑scale deliveries in 2027 confirm repeatable CAPEX and LCOH improvements
• Watch for Nel's review of the two idle 500 MW atmospheric lines for potential write‑downs or asset redeployments that could meaningfully impact the balance sheet